Contactin 2 and contactin-associated protein 2 antibodies in patients with multiple sclerosis and clinically isolated syndrome
Autores principales: | Nytrova, P, Waters, P, Horakova, D, Hacohen, Y, Kalincik, T, Zbornikova, P, Blahova, J, Krasensky, J, Vaneckova, M, Havrdova, E, Wandinger, K, Vincent, A |
---|---|
Formato: | Conference item |
Publicado: |
2012
|
Ejemplares similares
-
No evidence for association of autism with rare heterozygous point mutations in Contactin-Associated Protein-Like 2 (CNTNAP2), or in Other Contactin-Associated Proteins or Contactins.
por: John D Murdoch, et al.
Publicado: (2015-01-01) -
Association of leucine-rich glioma inactivated protein 1, contactin-associated protein 2, and contactin 2 antibodies with clinical features and patient-reported pain in acquired neuromyotonia
por: Vincent, A, et al.
Publicado: (2018) -
Contactin-associated protein-2 antibodies in non-paraneoplastic cerebellar ataxia.
por: Becker, E, et al.
Publicado: (2012) -
Contactin-associated protein-2 antibodies in non-paraneoplastic cerebellar ataxia.
por: Becker, E, et al.
Publicado: (2012) -
Implication of Contactins in Demyelinating Pathologies
por: Ilias Kalafatakis, et al.
Publicado: (2021-01-01)